Αποτελέσματα Αναζήτησης
28 Απρ 2024 · For those with diabetes and hypertension, additional lifestyle modification beyond reducing sodium intake can be helpful, including: loss of excess body weight; increasing consumption of vegetables and fruit (8 –10 servings/day), and low-fat dairy products (2–3 servings/day); avoiding excessive alcohol consumption (no more than 2 servings ...
Treatment overview. This treatment regimen consists of two parts: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Breast neoadjuvant/adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly. Breast adjuvant TH (DOCEtaxel and trastuzumab) three weekly.
20 Νοε 2023 · If your doctor recommends it, even a modest amount of weight loss — around 5% — can improve blood sugar management and other diabetes outcomes. This article focuses on specific eating options...
This protocol is part of the AC-TH regimen: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Link to Breast adjuvant AC-TH overview; Link to Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly; Drug status: Docetaxel is on the PBS general schedule. Trastuzumab is PBS authority
17 Νοε 2021 · Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods.
1 Μαΐ 2018 · Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) is a Chemotherapy Regimen for Breast Cancer - early stage. How does Dose-Dense AC + TH work? Doxorubicin, cyclophosphamide, and paclitaxel are designed to kill or slow the growth of cancer cells.
27 Οκτ 2023 · Accordingly, we conducted a 6-month, randomized clinical trial comparing the effects of 8-hour TRE (eating all food between 12:00 pm and 8:00 pm, without calorie counting) with CR (25% restriction daily) and a control condition on body weight and glycemic control in a group of adults with T2D and obesity.
